SAMANTHA GOULD: Open Payments
NPI 1841936994 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 65 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $496 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $186 |
| Amgen Inc. | 10 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $136 |
| Merck Sharp & Dohme LLC | 6 | $127 |
| PFIZER INC. | 5 | $105 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $97 |
| Novo Nordisk Inc | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| MEDICOMP INC | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
Products named: CAMZYOS, Repatha, JARDIANCE, ELIQUIS, VERQUVO, LifeVest, Wegovy, LEQVIO.
Industry payments across PA — which companies pay providers there.
